Top 10 Chinese Herbal Medicine Companies: Origins, Therapeutic Focus & Highlights
11 October 2025 Category: Clinical TrialThe global herbal medicine market is booming, and at its heart lies Traditional Chinese Medicine (TCM).
The global herbal medicine market is booming, and at its heart lies Traditional Chinese Medicine (TCM).
Antimicrobial resistance (AMR) is getting scary. Experts say that by 2050, it could cause 10 million deaths every year if we don’t act.
Generics and biosimilars both make drugs cheaper, but they behave very differently after a patent dies.
For pharma leaders, investors, and business development teams, these five years represent both risk and opportunity on a historic scale.
Here’s what that means: traditional anticoagulants—like warfarin and LMWHs—still form the backbone of hospital and community care
Companies have realized the era of innovation and advance drug developments is around the corner. One of the key areas that is witnessing a surge is monoclonal antibodies.
Artificial intelligence (AI) has become a transformative force in the increasingly digitized healthcare environment.
2025 is not just another year, a wave of innovation is crashing through biotech and bioinformatics, reshaping every stage of clinical development.
AI is no longer a distant vision in healthcare. It’s a $13.8 billion market today—and it's projected to soar past $164 billion by 2029. That’s over 1,000% growth in just a few years.
Clinical trials are drowning in data. That's not hyperbole—it's mathematics.